Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY23.31 CNY
Change Today -0.26 / -1.10%
Volume 20.9M
002118 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

jilin zixin pharmaceutical-a (002118) Snapshot

Open
CNY23.73
Previous Close
CNY23.57
Day High
CNY24.37
Day Low
CNY22.58
52 Week High
05/22/15 - CNY24.37
52 Week Low
12/29/14 - CNY11.80
Market Cap
12.0B
Average Volume 10 Days
19.8M
EPS TTM
CNY0.09
Shares Outstanding
513.0M
EX-Date
03/23/15
P/E TM
260.2x
Dividend
CNY0.04
Dividend Yield
0.16%
Current Stock Chart for JILIN ZIXIN PHARMACEUTICAL-A (002118)

Related News

No related news articles were found.

jilin zixin pharmaceutical-a (002118) Related Businessweek News

No Related Businessweek News Found

jilin zixin pharmaceutical-a (002118) Details

Jilin Zixin Pharmaceutical Industrial Co., Ltd researches, develops, manufactures, and sells traditional Chinese patent drugs in China. It is also involved the plantation of medicinal materials. The company provides Huoxue Tongmai tablets, Simiao pills, Fufang Yigan tablets, Xingnao Zaizao capsules, Shen Fukang capsules, Bushen Anshen oral solutions, Liuwei Dihuang capsules, ginseng products, Shexiang Jiegu capsules, and other products. It primarily offers drugs for the treatment of cardiovascular and cerebrovascular diseases, digestive system diseases, and bone fractures. The company is based in Tonghua, China.

jilin zixin pharmaceutical-a (002118) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jilin zixin pharmaceutical-a (002118) Key Developments

Jilin Zixin Pharmaceutical Industrial Co.,Ltd to Report Q1, 2015 Results on Apr 24, 2015

Jilin Zixin Pharmaceutical Industrial Co.,Ltd announced that they will report Q1, 2015 results on Apr 24, 2015

Jilin Zixin Pharmaceutical Industrial Co., Ltd. Proposes Amendments to its Articles of Association

Jilin Zixin Pharmaceutical Industrial Co. Ltd. proposed the amendments to the articles of association of the company in the annual general meeting to be held on April 20, 2015.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd Proposes Cash Dividend for the Year 2014

Jilin Zixin Pharmaceutical Industrial Co.,Ltd proposed a cash dividend of CNY 3.00000000 per 10 shares (tax included) for the year 2014, at its AGM held on April 20, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002118:CH CNY23.31 CNY -0.26

002118 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002118.
View Industry Companies
 

Industry Analysis

002118

Industry Average

Valuation 002118 Industry Range
Price/Earnings 100.0x
Price/Sales 17.0x
Price/Book 5.7x
Price/Cash Flow 254.1x
TEV/Sales 15.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN ZIXIN PHARMACEUTICAL-A, please visit www.jilinzixin.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.